APIFARMA
APIFARMA is dedicated to representing and supporting the Portuguese pharmaceutical industry. Its mission is to promote innovation, sustainability, and the internationalization of pharmaceutical companies, ensuring access to quality healthcare and fostering economic growth through export and research initiatives. The organization actively collaborates on strategic health policies, education, and international projects to enhance the sector's global competitiveness and contribution to society. It also advocates for increased investment in clinical trials, addresses chronic underfunding of the National Health Service, promotes the internationalization of pharmaceutical companies, and fosters health literacy through programs like 'Tratar de Mim'. The organization engages in institutional relations at national and international levels, supports environmental management of pharmaceutical waste, and promotes research, publications, and public awareness campaigns.
Industries
Nr. of Employees
small (1-50)
Products
National pharmaceutical internationalisation program
A strategic program to promote export capacity, cooperative initiatives and the international visibility of domestically produced pharmaceuticals through company cooperation and incorporation of R&D.
National clinical trials partnership
A partnership initiative to strengthen the national clinical trials ecosystem, including coordination between research centres, sponsors and dissemination of trial statistics.
National clinical trials information platform
Digital aggregator providing centralized information on ongoing and planned clinical research to support trial recruitment, site identification and stakeholder access to clinical research data.
Public health literacy materials and outreach program
A health literacy program providing downloadable leaflets, posters, school activities and an educational game to promote responsible self-care and appropriate use of over-the-counter medicines.
Scholarship and awards programmes
Institutional scholarship scheme and annual awards program recognising merit in academic work and health journalism.
Medicine supply collaboration protocols (Via Verde and related reports)
Published collaboration protocols and reports that address medicine supply, characterization of supply failures and coordinated measures to improve availability and response to shortages.
National pharmaceutical internationalisation program
A strategic program to promote export capacity, cooperative initiatives and the international visibility of domestically produced pharmaceuticals through company cooperation and incorporation of R&D.
National clinical trials partnership
A partnership initiative to strengthen the national clinical trials ecosystem, including coordination between research centres, sponsors and dissemination of trial statistics.
National clinical trials information platform
Digital aggregator providing centralized information on ongoing and planned clinical research to support trial recruitment, site identification and stakeholder access to clinical research data.
Public health literacy materials and outreach program
A health literacy program providing downloadable leaflets, posters, school activities and an educational game to promote responsible self-care and appropriate use of over-the-counter medicines.
Scholarship and awards programmes
Institutional scholarship scheme and annual awards program recognising merit in academic work and health journalism.
Medicine supply collaboration protocols (Via Verde and related reports)
Published collaboration protocols and reports that address medicine supply, characterization of supply failures and coordinated measures to improve availability and response to shortages.
Services
Annual and on-demand training programs covering technical, regulatory, economic and professional topics delivered via in-person courses, live online sessions and asynchronous e-learning; includes course administration and certification workflows.
Representation and engagement with national and international authorities and sector associations to influence health policy, regulation and funding affecting the pharmaceutical sector.
Programmatic support to increase export opportunities and international visibility for domestically manufactured pharmaceuticals and related services, including partnerships to foster cooperation and R&D incorporation.
Coordination and funding of an integrated national system for collection, secure storage and safe final treatment of medicine packaging and unused medicines, working with pharmacies and waste management stakeholders.
Organises stakeholder convenings, workshops and policy dialogues on digital health topics including interoperability, data governance, AI and telehealth to support regulatory acceptance and ecosystem development.
Analytical and coordination services addressing medicine availability, including collaborative projects and protocols to identify causes of shortages and propose mitigation measures with regulators and supply chain partners.
Annual and on-demand training programs covering technical, regulatory, economic and professional topics delivered via in-person courses, live online sessions and asynchronous e-learning; includes course administration and certification workflows.
Representation and engagement with national and international authorities and sector associations to influence health policy, regulation and funding affecting the pharmaceutical sector.
Programmatic support to increase export opportunities and international visibility for domestically manufactured pharmaceuticals and related services, including partnerships to foster cooperation and R&D incorporation.
Coordination and funding of an integrated national system for collection, secure storage and safe final treatment of medicine packaging and unused medicines, working with pharmacies and waste management stakeholders.
Organises stakeholder convenings, workshops and policy dialogues on digital health topics including interoperability, data governance, AI and telehealth to support regulatory acceptance and ecosystem development.
Analytical and coordination services addressing medicine availability, including collaborative projects and protocols to identify causes of shortages and propose mitigation measures with regulators and supply chain partners.
Expertise Areas
- Clinical trial network development and coordination
- Digital health policy and stakeholder engagement
- Real-world evidence and health data analytics
- Regulatory and public policy advocacy
Key Technologies
- Digital clinical trials information platforms
- E-learning platforms (synchronous and asynchronous)
- AI and machine learning for diagnostics and decision support
- Real-world evidence and big data analytics
News & Updates
Discussion on the implementation of the HTA regulation at APIFARMA.
APIFARMA awards recognizing quality journalism that contributes to health literacy.
APIFARMA advocates for the enhancement of therapeutic innovation and faster access to medicines for Portuguese citizens.
Discussion on the implementation of the HTA regulation at APIFARMA.
APIFARMA awards recognizing quality journalism that contributes to health literacy.
APIFARMA advocates for the enhancement of therapeutic innovation and faster access to medicines for Portuguese citizens.